Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22654549 | 0.81 | — | — | |
| SCHEMBL1205159 | 0.81 | — | — | |
| SCHEMBL12153610 | 0.77 | — | — | |
| SCHEMBL18272303 | 0.74 | — | — | |
| Methane SCHEMBL28569181 | 0.70 | MAPT (0.39) | — | |
| SCHEMBL28559422 | 0.65 | NPC1 (0.33) | — | |
| SCHEMBL10781014 | 0.63 | ALOX15 (0.33) | — | |
| SCHEMBL4360617 | 0.62 | — | — | |
| SCHEMBL29221161 | 0.60 | — | — | |
| SCHEMBL21661924 | 0.59 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10256506-B2 | Electrolyte, electrochemical device, secondary cell, and module | DAIKIN INDUSTRIES, LTD. (JP) | 2019-04-09 | — | — | US | disclosed |
| US-10256506-B2 | Electrolyte, electrochemical device, secondary cell, and module | DAIKIN INDUSTRIES, LTD. (JP) | 2019-04-09 | — | — | US | disclosed |
| US-20160351957-A1 | ELECTROLYTE, ELECTROCHEMICAL DEVICE, SECONDARY CELL, AND MODULE | DAIKIN INDUSTRIES, LTD. (JP) | 2016-12-01 | — | — | US | disclosed |
| US-20160351957-A1 | ELECTROLYTE, ELECTROCHEMICAL DEVICE, SECONDARY CELL, AND MODULE | DAIKIN INDUSTRIES, LTD. (JP) | 2016-12-01 | — | — | US | disclosed |
| US-20160351957-A1 | ELECTROLYTE, ELECTROCHEMICAL DEVICE, SECONDARY CELL, AND MODULE | DAIKIN INDUSTRIES, LTD. (JP) | 2016-12-01 | — | — | US | disclosed |
| EP-2220073-B1 | PYRIDAZINONE DERIVATIVES AS PARP INHIBITORS | MSD ITALIA SRL (IT) | 2014-09-03 | — | — | EP | disclosed |
| US-8268827-B2 | Pyridazinone derivatives as PARP inhibitors | ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA. (IT) | 2012-09-18 | — | — | US | disclosed |
| US-20100261709-A1 | PYRIDAZINONE DERIVATIVES AS PARP INHIBITORS | MSD ITALIA S.R.L. (IT) | 2010-10-14 | — | — | US | disclosed |
| EP-2220073-A1 | PYRIDAZINONE DERIVATIVES AS PARP INHIBITORS | Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. (IT) | 2010-08-25 | — | — | EP | disclosed |
| WO-2009063244-A1 | PYRIDAZINONE DERIVATIVES AS PARP INHIBITORS | ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI S.P.A. (IT) | 2009-05-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100261709-A1 | PYRIDAZINONE DERIVATIVES AS PARP INHIBITORS | PARP1, PARP2, PARP3 | ELANE 3207/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.